Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: June 2011

Chapter 13 - Intracranial arteriovenous malformations

References

1. WarlowCP. Stroke: A Practical Guide to Management. 2nd edn: Wiley-Blackwell, 2000.
2. MohrJP. Stroke: Pathophysiology, Diagnosis, and Management. 4th edn: Chuchill Livingstone, 2004.
3. RinkelGJ. Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol 2005;4:122–8.
4. WikholmG, LundqvistC, SvendsenP. Embolization of cerebral arteriovenous malformations: Part I – Technique, morphology, and complications. Neurosurgery 1996;39:448–57; discussion 57–9.
5. MiyamotoS, HashimotoN, NagataI, et al. Posttreatment sequelae of palliatively treated cerebral arteriovenous malformations. Neurosurgery 2000;46:589–94; discussion 594–5.
6. HanPP, PonceFA, SpetzlerRF. Intention-to-treat analysis of Spetzler– Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg 2003;98:3–7.
7. PerretG, NishiokaH.Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Section VI. Arteriovenous malformations. An analysis of 545 cases of cranio-cerebral arteriovenous malformations and fistulae reported to the cooperative study. J Neurosurg 1966;25:467–90.
8. McCormickWF, RosenfieldDB. Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke 1973;4:946–54.
9. JessurunGA, KamphuisDJ, van der ZandeFH, NossentJC. Cerebral arteriovenous malformations in The Netherlands Antilles. High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg 1993;95:193–8.
10. BrownRD, Jr., WiebersDO, TornerJC, O'FallonWM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg 1996;85:29–32.
11. BrownRD, Jr., WiebersDO, TornerJC, O'FallonWM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology 1996;46:949–52.
12. StapfC, MastH, SciaccaRR, et al. The New York Islands AVM Study: design, study progress, and initial results. Stroke 2003;34:e29–33.
13. CampiA, ScottiG, FilippiM, GereviniS, StrigimiF, LasjauniasP. Antenatal diagnosis of vein of Galen aneurysmal malformation: MR study of fetal brain and postnatal follow-up. Neuroradiology 1996;38:87–90.
14. YuvalY, LernerA, LipitzS, RotsteinZ, HegeshJ, AchironR. Prenatal diagnosis of vein of Galen aneurysmal malformation: report of two cases with proposal for prognostic indices. Prenat Diagn 1997;17:972–7.
15. MullanS, MojtahediS, JohnsonDL, MacdonaldRL. Embryological basis of some aspects of cerebral vascular fistulas and malformations. J Neurosurg 1996;85:1–8.
16. NelsonMD, Jr., Gonzalez-GomezI, GillesFH. Dyke Award. The search for human telencephalic ventriculofugal arteries. Am J Neuroradiol 1991;12:215–22.
17. HashimotoT, Mesa-TejadaR, QuickCM, et al. Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery 2001;49:124–31; discussion 131–2.
18. VikkulaM, BoonLM, CarrawayKL, 3rd, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181–90.
19. HashimotoT, LamT, BoudreauNJ, BollenAW, LawtonMT, YoungWL. Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 2001;89:111–13.
20. RothbartD, AwadIA, LeeJ, KimJ, HarbaughR, CriscuoloGR. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 1996;38:915–24; discussion 924–5.
21. HashimotoT, EmalaCW, JoshiS, et al. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 2000;47:910–18; discussion 918–19.
22. MalikG, AbdulraufS, YangXY, GutierrezJA, RempelSA. Expression of transforming growth factor-beta complex in arteriovenous malformations. Neurol Med Chir (Tokyo) 1998;38 Suppl:161–4.
23. HirschiKK, RohovskySA, D'AmorePA. PDGF, TGF-beta, and heterotypic cell–cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998;141:805–14.
24. SonsteinWJ, KaderA, MichelsenWJ, LlenaJF, HiranoA, CasperD. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study. J Neurosurg 1996;85:838–45.
25. MatsubaraS, BourdeauA, terBruggeKG, WallaceC, LetarteM. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Stroke 2000;31:2653–60.
26. AbdulraufSI, MalikGM, AwadIA. Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery 1999;44:280–7; discussion 287–8.
27. KaderA, GoodrichJT, SonsteinWJ, SteinBM, CarmelPW, MichelsenWJ. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg 1996;85:14–18.
28. HashimotoN, NozakiK. Do cerebral arteriovenous malformations recur after angiographically confirmed total extirpation?Crit Rev Neurosurg 1999;9:141–6.
29. SneadOC, 3rd, AckerJD, MorawetzR. Familial arteriovenous malformation. Ann Neurol 1979;5:585–7.
30. GerosaMA, CappellottoP, LicataC, IraciG, PardatscherK, FioreDL. Cerebral arteriovenous malformations in children (56 cases). Childs Brain 1981;8:356–71.
31. BoydMC, SteinbokP, PatyDW. Familial arteriovenous malformations. Report of four cases in one family. J Neurosurg 1985;62:597–9.
32. BarreRG, SuterCG, RosenblumWI. Familial vascular malformation or chance occurrence? Case report of two affected family members. Neurology 1978;28:98–100.
33. HerzigR, BurvalS, VladykaV, et al. Familial occurrence of cerebral arteriovenous malformation in sisters: case report and review of the literature. Eur J Neurol 2000;7:95–100.
34. PutmanCM, ChaloupkaJC, FulbrightRK, AwadIA, WhiteRI, Jr., FayadPB. Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu syndrome). Am J Neuroradiol 1996;17:1733–42.
35. KadoyaC, MomotaY, IkegamiY, UrasakiE, WadaS, YokotaA. Central nervous system arteriovenous malformations with hereditary hemorrhagic telangiectasia: report of a family with three cases. Surg Neurol 1994;42:234–9.
36. WillinskyRA, LasjauniasP, TerbruggeK, BurrowsP. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology 1990;32:207–10.
37. RuigrokYM, RinkelGJ, WijmengaC. Genetics of intracranial aneurysms. Lancet Neurol 2005;4:179–89.
38. KupersmithMJ, VargasME, YasharA, et al. Occipital arteriovenous malformations: visual disturbances and presentation. Neurology 1996;46:953–7.
39. LobatoRD, RivasJJ, GomezPA, CabreraA, SarabiaR, LamasE. Comparison of the clinical presentation of symptomatic arteriovenous malformations (angiographically visualized) and occult vascular malformations. Neurosurgery 1992;31:391–6; discussion 396–7.
40. MaedaK, KuritaH, NakamuraT, et al. Occurrence of severe vasospasm following intraventricular hemorrhage from an arteriovenous malformation. Report of two cases. J Neurosurg 1997;87:436–9.
41. MastH, MohrJP, Osipov A, et al. ‘Steal’ is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke 1995;26:1215–20.
42. WilkinsRH. Natural history of intracranial vascular malformations: a review. Neurosurgery 1985;16:421–30.
43. BrownRD, Jr., WiebersDO, ForbesG, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988;68:352–7.
44. GarridoE, SteinB. Removal of an arteriovenous malformation from the basal ganglion. J Neurol Neurosurg Psychiatry 1978;41:992–5.
45. TurjmanF, MassoudTF, SayreJW, VinuelaF, GuglielmiG, DuckwilerG. Epilepsy associated with cerebral arteriovenous malformations: a multivariate analysis of angioarchitectural characteristics. Am J Neuroradiol 1995;16:345–50.
46. StapfC, MohrJP, SciaccaRR, et al. Incident hemorrhage risk of brain arteriovenous malformations located in the arterial borderzones. Stroke 2000;31:2365–8.
47. LeesF. The migrainous symptoms of cerebral angiomata. J Neurol Neurosurg Psychiatry 1962;25:45–50.
48. HaasDC. Arteriovenous malformations and migraine: case reports and an analysis of the relationship. Headache 1991;31:509–13.
49. BruynGW. Intracranial arteriovenous malformation and migraine. Cephalalgia 1984;4:191–207.
50. EvansRW. Diagnostic testing for the evaluation of headaches. Neurol Clin 1996;14:1–26.
51. HofmeisterC, StapfC, HartmannA, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke 2000;31:1307–10.
52. HillmanJ. Population-based analysis of arteriovenous malformation treatment. J Neurosurg 2001;95:633–7.
53. SimonHT, ReefH, PhadkeRV, PopovicEA. A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke 2002;33:2794–800.
54. KhawAV, MohrJP, SciaccaRR, et al. Association of infratentorial brain arteriovenous malformations with hemorrhage at initial presentation. Stroke 2004;35:660–3.
55. HalimAX, JohnstonSC, SinghV, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 2004;35:1697–702.
56. JaillardAS, PeresB, HommelM. Neuropsychological features of dementia due to dural arteriovenous malformation. Cerebrovasc Dis 1999;9:91–7.
57. MiyasakaY, KurataA, TanakaR, et al. Mass effect caused by clinically unruptured cerebral arteriovenous malformations. Neurosurgery 1997;41:1060–3; discussion 1063–4.
58. KonanAV, RoyD, RaymondJ. Endovascular treatment of hemifacial spasm associated with a cerebral arteriovenous malformation using transvenous embolization: case report. Neurosurgery 1999;44:663–6.
59. OndraSL, TrouppH, GeorgeED, SchwabK. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990;73:387–91.
60. AminoffMJ. Treatment of unruptured cerebral arteriovenous malformations. Neurology 1987;37:815–19.
61. JaneJA, KassellNF, TornerJC, WinnHR. The natural history of aneurysms and arteriovenous malformations. J Neurosurg 1985;62:321–3.
62. MastH, YoungWL, KoenneckeHC, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 1997;350:1065–8.
63. KondziolkaD, McLaughlinMR, KestleJR. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery 1995;37:851–5.
64. BrownRD, Jr. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery 2000;46:1024.
65. GrafCJ, PerretGE, TornerJC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 1983;58:331–7.
66. ForsterDM, SteinerL, HakansonS. Arteriovenous malformations of the brain. A long-term clinical study. J Neurosurg 1972;37:562–70.
67. FultsD, KellyDL, Jr. Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery 1984;15:658–62.
68. ItoyamaY, UemuraS, UshioY, et al. Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases. J Neurosurg 1989;71:805–9.
69. KrayenbuehlH, SiebenmannR. Small Vascular Malformations as a Cause of Primary Intracerebral Hemorrhage. J Neurosurg 1965;22:7–20.
70. PollockBE, FlickingerJC, LunsfordLD, BissonetteDJ, KondziolkaD. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke 1996;27:1–6.
71. LangerDJ, LasnerTM, HurstRW, FlammES, ZagerEL, KingJT, Jr.Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery 1998;42:481–6; discussion 487–9.
72. DuongDH, YoungWL, VangMC, et al. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke 1998;29:1167–76.
73. MarksMP, LaneB, SteinbergGK, ChangPJ. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology 1990;176:807–13.
74. MiyasakaY, YadaK, OhwadaT, KitaharaT, KurataA, IrikuraK. An analysis of the venous drainage system as a factor in hemorrhage from arteriovenous malformations. J Neurosurg 1992;76:239–43.
75. YoungWL, ProhovnikI, OrnsteinE, et al. The effect of arteriovenous malformation resection on cerebrovascular reactivity to carbon dioxide. Neurosurgery 1990;27:257–66; discussion 266–7.
76. KusskeJA, KellyWA. Embolization and reduction of the “steal” syndrome in cerebral arteriovenous malformations. J Neurosurg 1974;40:313–21.
77. TurjmanF, MassoudTF, VinuelaF, SayreJW, GuglielmiG, DuckwilerG. Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery 1995;37:856–60; discussion 860–2.
78. RedekopG, TerBruggeK, MontaneraW, WillinskyR. Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg 1998;89:539–46.
79. StapfC, MastH, SciaccaRR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66:1350–5.
80. HartmannA, MastH, MohrJP, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998;29:931–4.
81. KumarAJ, FoxAJ, VinuelaF, RosenbaumAE. Revisited old and new CT findings in unruptured larger arteriovenous malformations of the brain. J Comput Assist Tomogr 1984;8:648–55.
82. TanakaH, NumaguchiY, KonnoS, ShrierDA, ShibataDK, PatelU. Initial experience with helical CT and 3D reconstruction in therapeutic planning of cerebral AVMs: comparison with 3D time-of-flight MRA and digital subtraction angiography. J Comput Assist Tomogr 1997;21:811–17.
83. HustonJ, 3rd, RufenachtDA, EhmanRL, WiebersDO. Intracranial aneurysms and vascular malformations: comparison of time-of-flight and phase-contrast MR angiography. Radiology 1991;181:721–30.
84. KucharczykW, Lemme-PleghosL, UskeA, Brant-ZawadzkiM, DoomsG, NormanD. Intracranial vascular malformations: MR and CT imaging. Radiology 1985;156:383–9.
85. SchlosserMJ, McCarthyG, FulbrightRK, GoreJC, AwadIA. Cerebral vascular malformations adjacent to sensorimotor and visual cortex. Functional magnetic resonance imaging studies before and after therapeutic intervention. Stroke 1997;28:1130–7.
86. LatchawRE, HuX, UgurbilK, HallWA, MadisonMT, HerosRC. Functional magnetic resonance imaging as a management tool for cerebral arteriovenous malformations. Neurosurgery 1995;37:619–25; discussion 625–6.
87. SalehRS, LohanDG, VillablancaJP, DuckwilerG, KeeST, FinnJP. Assessment of craniospinal arteriovenous malformations at 3T with highly temporally and highly spatially resolved contrast-enhanced MR angiography. Am J Neuroradiol 2008;29:1024–31.
88. TurjmanF, MassoudTF, VinuelaF, SayreJW, GuglielmiG, DuckwilerG. Aneurysms related to cerebral arteriovenous malformations: superselective angiographic assessment in 58 patients. Am J Neuroradiol 1994;15:1601–5.
89.Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 2001;32:1430–42.
90. TodakaT, HamadaJ, KaiY, MoriokaM, UshioY. Analysis of mean transit time of contrast medium in ruptured and unruptured arteriovenous malformations: a digital subtraction angiographic study. Stroke 2003;34:2410–14.
91. WakhlooAK, LieberBB, RudinS, FronckowiakMD, MericleRA, HopkinsLN. A novel approach to flow quantification in brain arteriovenous malformations prior to enbucrilate embolization: use of insoluble contrast (Ethiodol droplet) angiography. J Neurosurg 1998;89:395–404.
92. MorrisP. Practical Neuroangiography. 2nd edn: Lippincott Williams & Wilkins; 2007.
93. Pile-SpellmanJM, BakerKF, LiszczakTM, et al. High-flow angiopathy: cerebral blood vessel changes in experimental chronic arteriovenous fistula. Am J Neuroradiol 1986;7:811–15.
94. ValavanisA. The role of angiography in the evaluation of cerebral vascular malformations. Neuroimaging Clin N Am 1996;6:679–704.
95. Muller-ForellW, ValavanisA. How angioarchitecture of cerebral arteriovenous malformations should influence the therapeutic considerations. Minim Invasive Neurosurg 1995;38:32–40.
96. SpetzlerRF, MartinNA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–83.
97. TamakiN, EharaK, LinTK, et al. Cerebral arteriovenous malformations: factors influencing the surgical difficulty and outcome. Neurosurgery 1991;29:856–61; discussion 861–3.
98. PertuisetB, AncriD, KinutaY, et al. Classification of supratentorial arteriovenous malformations. A score system for evaluation of operability and surgical strategy based on an analysis of 66 cases. Acta Neurochir (Wien) 1991;110:6–16.
99. ShiYQ, ChenXC. A proposed scheme for grading intracranial arteriovenous malformations. J Neurosurg 1986;65:484–9.
100. HamiltonMG, SpetzlerRF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery 1994;34:2–6; discussion 7.
101. HerosRC, KorosueK, DieboldPM. Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery 1990;26:570–7; discussion 577–8.
102. LawtonMT. Spetzler-Martin Grade III arteriovenous malformations: surgical results and a modification of the grading scale. Neurosurgery 2003;52:740–8; discussion 748–9.
103. SpetzlerRF, HargravesRW, McCormickPW, ZabramskiJM, FlomRA, ZimmermanRS. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg 1992;76:918–23.
104. OgilvyCS, StiegPE, AwadI, et al. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation 2001;103:2644–57.
105. FiorellaD, AlbuquerqueFC, WooHH, McDougallCG, RasmussenPA. The role of neuroendovascular therapy for the treatment of brain arteriovenous malformations. Neurosurgery 2006;59:S163–77; discussion S3–13.
106. PurdyPD, BatjerHH, RisserRC, SamsonD. Arteriovenous malformations of the brain: choosing embolic materials to enhance safety and ease of excision. J Neurosurg 1992;77:217–22.
107. PurdyPD, BatjerHH, SamsonD, RisserRC, BowmanGW. Intraarterial sodium amytal administration to guide preoperative embolization of cerebral arteriovenous malformations. J Neurosurg Anesthesiol 1991;3:103–6.
108. JafarJJ, DavisAJ, BerensteinA, ChoiIS, KupersmithMJ. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 1993;78:60–9.
109. VinuelaF, DionJE, DuckwilerG, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 1991;75:856–64.
110. MorganMK, ZurinAA, HarringtonT, LittleN. Changing role for preoperative embolisation in the management of arteriovenous malformations of the brain. J Clin Neurosci 2000;7:527–30.
111. HartmannA, MastH, MohrJP, et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke 2005;36:2431–5.
112. CastelJP, KantorG. [Postoperative morbidity and mortality after microsurgical exclusion of cerebral arteriovenous malformations. Current data and analysis of recent literature]. Neurochirurgie 2001;47:369–83.
113. DeMerittJS, Pile-SpellmanJ, MastH, et al. Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations. Am J Neuroradiol 1995;16:1801–7.
114.N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. Am J Neuroradiol 2002;23:748–55.
115. LasjauniasP, PiskeR, TerbruggeK, WillinskyR. Cerebral arteriovenous malformations (C. AVM) and associated arterial aneurysms (AA). Analysis of 101 C. AVM cases, with 37 AA in 23 patients. Acta Neurochir (Wien) 1988;91:29–36.
116. KimEJ, HalimAX, DowdCF, et al. The relationship of coexisting extranidal aneurysms to intracranial hemorrhage in patients harboring brain arteriovenous malformations. Neurosurgery 2004;54:1349–57; discussion 1357–8.
117. BrownRD, Jr., WiebersDO, ForbesGS. Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg 1990;73:859–63.
118. KwonY, JeonSR, KimJH, et al. Analysis of the causes of treatment failure in gamma knife radiosurgery for intracranial arteriovenous malformations. J Neurosurg 2000;93 Suppl 3:104–6.
119. SteinerL, LindquistC, AdlerJR, TornerJC, AlvesW, SteinerM. Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg 1992;77:1–8.
120. LunsfordLD, KondziolkaD, FlickingerJC, et al. Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 1991;75:512–24.
121. MaruyamaK, KawaharaN, ShinM, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005;352:146–53.
122. PollockBE. Stereotactic radiosurgery for arteriovenous malformations. Neurosurg Clin N Am 1999;10:281–90.
123. FlickingerJC, KondziolkaD, LunsfordLD, et al. A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys 1999;44:67–74.
124. GobinYP, LaurentA, MerienneL, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 1996;85:19–28.
125. HenkesH, NahserHC, Berg-DammerE, WeberW, LangeS, KuhneD. Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res 1998;20:479–92.
126. PollockBE, KondziolkaD, LunsfordLD, BissonetteD, FlickingerJC. Repeat stereotactic radiosurgery of arteriovenous malformations: factors associated with incomplete obliteration. Neurosurgery 1996;38:318–24.
127. RaoVR, MandalamKR, GuptaAK, KumarS, JosephS. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up. AJNR Am J Neuroradiol 1989;10:135–41.
128. FournierD, TerbruggeK, RodeschG, LasjauniasP. Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology 1990;32:497–501.
129. FournierD, TerBruggeKG, WillinskyR, LasjauniasP, MontaneraW. Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases. J Neurosurg 1991;75:228–33.
130. VinuelaF, DuckwilerG, GuglielmiG. Contribution of interventional neuroradiology in the therapeutic management of brain arteriovenous malformations. J Stroke Cerebrovasc Dis 1997;6:268–71.
131. ValavanisAC, G. Endovascular management of cerebral arteriovenous malformations. Neurointenterventionist 1999:34–40.
132. WeberW, KisB, SiekmannR, JansP, LaumerR, KuhneD. Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery 2007;61:244–52; discussion 252–4.
133. KatsaridisV, PapagiannakiC, AimarE. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008; 50 (7): 589–97.
134. MounayerC, HammamiN, PiotinM, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. Am J Neuroradiol 2007;28:518–23.
135. van RooijWJ, SluzewskiM, BeuteGN. Brain AVM embolization with Onyx. Am J Neuroradiol 2007;28:172–7; discussion 178.
136. LuessenhopAJ, MujicaPH. Embolization of segments of the circle of Willis and adjacent branches for management of certain inoperable cerebral arteriovenous malformations. J Neurosurg 1981;54:573–82.
137. FoxAJ, GirvinJP, VinuelaF, DrakeCG. Rolandic arteriovenous malformations: improvement in limb function by IBC embolization. Am J Neuroradiol 1985;6:575–82.
138. WikholmG, LundqvistC, SvendsenP. The Goteborg cohort of embolized cerebral arteriovenous malformations: a 6-year follow-up. Neurosurgery 2001;49:799–805; discussion 806.
139. SampeiK, HashimotoN, KazekawaK, TsukaharaT, IwataH, TakaichiS. Histological changes in brain tissue and vasculature after intracarotid infusion of organic solvents in rats. Neuroradiology 1996;38:291–4.
140. ChaloupkaJC, VinuelaF, VintersHV, RobertJ. Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. Am J Neuroradiol 1994;15:1107–15.
141. MurayamaY, VinuelaF, UlhoaA, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 1998;43:1164–75.
142. JahanR, MurayamaY, GobinYP, DuckwilerGR, VintersHV, VinuelaF. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001;48:984–95; discussion 995–7.
143. MazalPR, StichenwirthM, GruberA, SulzbacherI, HainfellnerJA. Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: a histopathological follow-up. Pathology 2006;38:28–32.
144. YuSC, ChanMS, LamJM, TamPH, PoonWS. Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure. AJNR Am J Neuroradiol 2004;25:1139–43.
145. YakesWF, RossiP, OdinkH. How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol 1996;19:65–71.
146. NakstadPH, BakkeSJ, HaldJK. Embolization of intracranial arteriovenous malformations and fistulas with polyvinyl alcohol particles and platinum fibre coils. Neuroradiology 1992;34:348–51.
147. WakhlooAK, JuenglingFD, Van VelthovenV, SchumacherM, HennigJ, SchwechheimerK. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. Am J Neuroradiol 1993;14:571–82.
148. SorimachiT, KoikeT, TakeuchiS, et al. Embolization of cerebral arteriovenous malformations achieved with polyvinyl alcohol particles: angiographic reappearance and complications. Am J Neuroradiol 1999;20:1323–8.
149. MathisJA, BarrJD, HortonJA, et al. The efficacy of particulate embolization combined with stereotactic radiosurgery for treatment of large arteriovenous malformations of the brain. Am J Neuroradiol 1995;16:299–306.
150. ManninenPH, GignacEM, GelbAW, LownieSP. Anesthesia for interventional neuroradiology. J Clin Anesth 1995;7:448–52.
151. ManninenPH, ChanAS, PapworthD. Conscious sedation for interventional neuroradiology: a comparison of midazolam and propofol infusion. Can J Anaesth 1997;44:26–30.
152. Pile-SpellmanJ, YoungWL, JoshiS, et al. Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations: technical case report. Neurosurgery 1999;44:881–6; discussion 886–7.
153. HanMH, ChangKH, HanDH, YeonKM, HanMC. Preembolization functional evaluation in supratentorial cerebral arteriovenous malformations with superselective intraarterial injection of thiopental sodium solution. Acta Radiol 1994;35:212–16.
154. MooLR, MurphyKJ, GailloudP, TesoroM, HartJ. Tailored cognitive testing with provocative amobarbital injection preceding AVM embolization. Am J Neuroradiol 2002;23:416–21.
155. RauchRA, VinuelaF, DionJ, et al. Preembolization functional evaluation in brain arteriovenous malformations: the superselective Amytal test. Am J Neuroradiol 1992;13:303–8.
156. YoungWL, Pile-SpellmanJ. Anesthetic considerations for interventional neuroradiology. Anesthesiology 1994;80:427–56.
157. JafarJJ, TanWS, CrowellRM. Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report. J Neurosurg 1991;74:808–12.
158. VelatGJ, Reavey-CantwellJF, SistromC, et al. Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times. Neurosurgery 2008;63:ONS73–8; discussion ON78–80.
160. PierotLHD, CognardC, FransenH, et al. Interventional Neuroradiology 2009;15:121–4.
161. JayaramanMV, MarcellusML, HamiltonS, et al. Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. Am J Neuroradiol 2008;29:242–6.
162. AletichVADG. Intracranial Arteriovenous Malformations: The Approach and Technique of Cyanoacrylate Embolization. Philadelphia: WB Saunders, 1999.
163. HoudartEME, PorcherR, BressonD, Saint-MauriceJP, BousserMG, StapfC. Interventional NeuroRadiology 2009;15:121–4.
164. PiepgrasDG, SundtTM, Jr., RagoowansiAT, StevensL. Seizure outcome in patients with surgically treated cerebral arteriovenous malformations. J Neurosurg 1993;78:5–11.
165. HeikkinenER, KonnovB, MelnikovL, et al. Relief of epilepsy by radiosurgery of cerebral arteriovenous malformations. Stereotact Funct Neurosurg 1989;53:157–66.